Company: DHR
Filing Date: 2025-03-26
Form Type: ARS
Source: 0000313616-25-000085
Chunk: 125

Company: DANAHER CORP /DE/
Filing Date: 2025-03-26
Form: ARS
Chunk 125
---
 related to the calculation of net earnings per common share from continuing operations for the years ended December 31 is summarized as follows ($ and shares in millions, except per share amounts): 2024 2023 2022 Numerator: Net earnings from continuing operations $ 3,899 $ 4,221 $ 6,328 MCPS dividends — (21) (106) Net earnings from continuing operations attributable to common stockholders for Basic EPS 3,899 4,200 6,222 Adjustment for MCPS dividends for dilutive MCPS — — 20 Net earnings from continuing operations attributable to common stockholders after assumed conversions for Diluted EPS $ 3,899 $ 4,200 $ 6,242 Denominator: Weighted average common shares outstanding used in Basic EPS 731.0 736.5 725.1 Incremental common shares from: Assumed exercise of dilutive options and vesting of dilutive RSUs and PSUs 6.2 6.6 9.0 Weighted average MCPS converted shares — — 3.0 Weighted average common shares outstanding used in Diluted EPS 737.2 743.1 737.1 Basic EPS from continuing operations $ 5.33 $ 5.70 $ 8.58 Diluted EPS from continuing operations $ 5.29 $ 5.65 $ 8.47 69

NOTE 5. REVENUE The following table presents the Company’s revenues disaggregated by geographical region and revenue type ($ in millions). Sales taxes and other usage-based taxes collected from customers are excluded from revenue. Biotechnology Life Sciences Diagnostics Total Year ended December 31, 2024: Geographical region: North America(a) $ 2,237 $ 3,199 $ 4,859 $ 10,295 Western Europe 2,296 1,574 1,587 5,457 Other developed markets(b) 335 510 408 1,253 High-growth markets(c) 1,891 2,046 2,933 6,870 Total $ 6,759 $ 7,329 $ 9,787 $ 23,875 Revenue type: Recurring $ 5,758 $ 4,889 $ 8,719 $ 19,366 Nonrecurring 1,001 2,440 1,068 4,509 Total $ 6,759 $ 7,329 $ 9,787